Charles Schwab’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$72.8M Buy
448,808
+3,209
+0.7% +$464K 0.01% 983
2026
Q1
$52.6M Buy
445,599
+3,832
+0.9% +$503K 0.01% 1122
2025
Q4
$52.6M Sell
441,767
-539
-0.1% -$61.4K 0.01% 1127
2025
Q3
$44.3M Sell
442,306
-8,881
-2% -$1.06M 0.01% 1234
2025
Q2
$58.2M Buy
451,187
+13,071
+3% +$1.59M 0.01% 1008
2025
Q1
$56M Sell
438,116
-2,073
-0.5% -$298K 0.01% 996
2024
Q4
$67.2M Buy
440,189
+799
+0.2% +$135K 0.01% 901
2024
Q3
$78.6M Buy
439,390
+4,271
+1% +$742K 0.02% 806
2024
Q2
$71M Buy
435,119
+8,333
+2% +$1.35M 0.01% 818
2024
Q1
$74.6M Buy
426,786
+6,021
+1% +$988K 0.02% 766
2023
Q4
$70.9M Buy
420,765
+8,341
+2% +$1.22M 0.02% 745
2023
Q3
$59.2M Buy
412,424
+104,537
+34% +$17M 0.02% 778
2023
Q2
$56.7M Buy
307,887
+191
+0.1% +$31.2K 0.02% 790
2023
Q1
$49M Buy
307,696
+643
+0.2% +$98.7K 0.01% 847
2022
Q4
$41.7M Buy
307,053
+6,410
+2% +$897K 0.01% 936
2022
Q3
$34.8M Buy
300,643
+8,976
+3% +$1.22M 0.01% 995
2022
Q2
$35.4M Sell
291,667
-648
-0.2% -$81.5K 0.01% 986
2022
Q1
$41.6M Buy
292,315
+9,388
+3% +$1.33M 0.01% 1000
2021
Q4
$49.9M Buy
282,927
+10,386
+4% +$1.74M 0.01% 901
2021
Q3
$42.1M Buy
272,541
+7,613
+3% +$1.11M 0.01% 996
2021
Q2
$35.7M Buy
264,928
+10,481
+4% +$1.41M 0.01% 1109
2021
Q1
$33.6M Buy
254,447
+24,282
+11% +$3.19M 0.01% 1112
2020
Q4
$27.2M Buy
230,165
+1,761
+0.8% +$205K 0.01% 1183
2020
Q3
$24.1M Sell
228,404
-3,119
-1% -$330K 0.01% 1078
2020
Q2
$24.7M Buy
231,523
+14,974
+7% +$1.39M 0.01% 1032
2020
Q1
$17.3M Buy
216,549
+3,573
+2% +$319K 0.01% 1107
2019
Q4
$18.8M Buy
212,976
+3,601
+2% +$311K 0.01% 1250
2019
Q3
$17.1M Buy
209,375
+16,236
+8% +$1.32M 0.01% 1249
2019
Q2
$18.2M Buy
193,139
+5,476
+3% +$467K 0.01% 1198
2019
Q1
$15.9M Buy
187,663
+9,018
+5% +$677K 0.01% 1259
2018
Q4
$11.3M Sell
178,645
-108
-0.1% -$6.96K 0.01% 1377
2018
Q3
$12.2M Buy
178,753
+9,023
+5% +$633K 0.01% 1497
2018
Q2
$10.6M Buy
169,730
+13,301
+9% +$813K 0.01% 1568
2018
Q1
$8.16M Buy
156,429
+5,182
+3% +$284K 0.01% 1645
2017
Q4
$7.56M Buy
151,247
+4,001
+3% +$195K 0.01% 1664
2017
Q3
$6.42M Buy
147,246
+20,863
+17% +$811K 0.01% 1744
2017
Q2
$4.55M Buy
126,383
+10,863
+9% +$345K ﹤0.01% 1866
2017
Q1
$3.07M Buy
115,520
+6,138
+6% +$150K ﹤0.01% 2012
2016
Q4
$2.3M Sell
109,382
-1,569
-1% -$29.9K ﹤0.01% 2129
2016
Q3
$1.93M Buy
110,951
+12,281
+12% +$202K ﹤0.01% 2148
2016
Q2
$1.5M Buy
+98,670
New +$1.52M ﹤0.01% 2195

Other funds holding NOVT

Charles Schwab's NOVT Position: Q2 2026 in Review

Charles Schwab increased its Novanta (NOVT) stake by 0.72% in Q2 2026, buying an estimated $464K and bringing the position to 448,808 shares worth $72.8M. The position accounts for 0.01% of the portfolio, ranked #983.

Charles Schwab first reported a position in NOVT in Q2 2016 and has held it in 41 quarters since. The position peaked at $78.6M in Q3 2024. 388 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

  • Charles Schwab held 448,808 shares of Novanta worth $72.8M as of Q2 2026.
  • Charles Schwab bought 3,209 Novanta shares in Q2 2026, an estimated $464K.
  • Novanta made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #983 holding.
  • Charles Schwab first reported a position in Novanta in Q2 2016 and has held it in 41 quarters since.
  • Charles Schwab's Novanta position peaked at $78.6M in Q3 2024.
  • 388 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.